News & Updates
Filter by Specialty:
NEPA- and olanzapine-based regimens similarly effective at preventing CINV in early BC
In a post hoc analysis of two prospective studies, netupitant/palonosetron (NEPA) combined with dexamethasone has demonstrated similar efficacy vs a quadruplet regimen of olanzapine, aprepitant, ondansetron, and dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) in Chinese women with early breast cancer (BC) receiving doxorubicin/cyclophosphamide (AC) in Hong Kong.
NEPA- and olanzapine-based regimens similarly effective at preventing CINV in early BC
15 Mar 2023
Smoking, prolonged catheterization a major risk factor for UTI after radical hysterectomy
For women with cervical cancer who are undergoing radical hysterectomy, preoperative tobacco use and prolonged catheterization appear to contribute to an increased risk of developing postoperative catheter-associated urinary tract infections (UTIs), as reported in a study.
Smoking, prolonged catheterization a major risk factor for UTI after radical hysterectomy
13 Mar 2023
Erbium YAG laser shows potential for treating OAB, vaginal atrophy in postmenopausal women
Use of the Erbium-doped yttrium-aluminum-garnet (Erbium YAG) laser in postmenopausal women appears to improve symptoms of overactive bladder (OAB) and vaginal atrophy, as shown in a study.
Erbium YAG laser shows potential for treating OAB, vaginal atrophy in postmenopausal women
10 Mar 2023
Novel intravaginal device for postpartum bleeding passes muster in phase II trial
A less invasive intravaginal device that facilitates bimanual uterine compression appears to work well in the treatment of postpartum haemorrhage, according to the results of a phase II trial.
Novel intravaginal device for postpartum bleeding passes muster in phase II trial
09 Mar 2023
COVID-19 infection in early pregnancy ups risk of stillbirth
Pregnant women who contract COVID-19 during early and mid-pregnancy are at risk of stillbirth, but this risk may not be present when infection occurs at any time during the third trimester or before delivery, as reported in a study.
COVID-19 infection in early pregnancy ups risk of stillbirth
08 Mar 2023
Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS
In the treatment of polycystic ovary syndrome (PCOS), the combination of metformin plus oral contraceptives appears to benefit women without obesity, inducing favourable effects on glucose metabolism with no further harm on lipid metabolism, according to the results of a meta-analysis.